129 related articles for article (PubMed ID: 22682116)
1. Hemostatic factors, innate immunity and malignancy.
Degen JL; Palumbo JS
Thromb Res; 2012 Apr; 129 Suppl 1():S1-5. PubMed ID: 22682116
[TBL] [Abstract][Full Text] [Related]
2. The interplay between hemostasis and malignancy: the oral cancer paradigm.
Yapijakis C; Bramos A; Nixon AM; Ragos V; Vairaktaris E
Anticancer Res; 2012 May; 32(5):1791-800. PubMed ID: 22593463
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms coupling thrombin to metastasis and tumorigenesis.
Remiker AS; Palumbo JS
Thromb Res; 2018 Apr; 164 Suppl 1():S29-S33. PubMed ID: 29703481
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
Rak J; Klement P; Yu J
Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
[TBL] [Abstract][Full Text] [Related]
5. Genetic pathways linking hemostasis and cancer.
Garnier D; Magnus N; D'Asti E; Hashemi M; Meehan B; Milsom C; Rak J
Thromb Res; 2012 Apr; 129 Suppl 1():S22-9. PubMed ID: 22682129
[TBL] [Abstract][Full Text] [Related]
6. [Development and dissemination of malignant tumors and hemostasis].
Kher A; Hilgard P
Pathol Biol (Paris); 1982 Dec; 30(10):861-7. PubMed ID: 6760066
[TBL] [Abstract][Full Text] [Related]
7. Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo.
Flick MJ; Du X; Degen JL
Exp Biol Med (Maywood); 2004 Dec; 229(11):1105-10. PubMed ID: 15564436
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice.
Palumbo JS; Potter JM; Kaplan LS; Talmage K; Jackson DG; Degen JL
Cancer Res; 2002 Dec; 62(23):6966-72. PubMed ID: 12460914
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Tokajuk P; Ostrowska-Cichocka K; Kisiel W
Thromb Res; 2012 Apr; 129(4):e112-8. PubMed ID: 22424030
[TBL] [Abstract][Full Text] [Related]
10. Immune cells as anti-cancer therapeutic targets and tools.
Johansson M; Tan T; de Visser KE; Coussens LM
J Cell Biochem; 2007 Jul; 101(4):918-26. PubMed ID: 17265430
[TBL] [Abstract][Full Text] [Related]
11. [Development and dissemination of malignant tumors, and hemostasis].
Kher A; Hilgard P
Sem Hop; 1983 Apr; 59(17):1348-54. PubMed ID: 6306819
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination.
Palumbo JS
Semin Thromb Hemost; 2008 Mar; 34(2):154-60. PubMed ID: 18645920
[TBL] [Abstract][Full Text] [Related]
13. Natural immunity to cancer in humans.
Bindea G; Mlecnik B; Fridman WH; Pagès F; Galon J
Curr Opin Immunol; 2010 Apr; 22(2):215-22. PubMed ID: 20207124
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the hemostatic system to angiogenesis in cancer.
Wojtukiewicz MZ; Sierko E; Rak J
Semin Thromb Hemost; 2004 Feb; 30(1):5-20. PubMed ID: 15034794
[TBL] [Abstract][Full Text] [Related]
15. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
Picon A; Gold LI; Wang J; Cohen A; Friedman E
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
[TBL] [Abstract][Full Text] [Related]
16. Targeting innate immune pathways in cancer immunotherapy: state of the art.
Mastellos DC
J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.
Palumbo JS; Talmage KE; Massari JV; La Jeunesse CM; Flick MJ; Kombrinck KW; Hu Z; Barney KA; Degen JL
Blood; 2007 Jul; 110(1):133-41. PubMed ID: 17371949
[TBL] [Abstract][Full Text] [Related]
18. The immunologic consequences of laparoscopy in oncology.
Carter JJ; Whelan RL
Surg Oncol Clin N Am; 2001 Jul; 10(3):655-77. PubMed ID: 11685934
[TBL] [Abstract][Full Text] [Related]
19. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic abnormalities associated with cancer and its therapy.
Glassman AB
Ann Clin Lab Sci; 1997; 27(6):391-5. PubMed ID: 9433535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
